Quarterly ResultMay 14, 2026, 06:07 AM
Health In Tech Reiterates FY2026 Revenue Guidance of $45M-$50M
AI Summary
Health In Tech, Inc. hosted its first quarter 2026 earnings conference call, reporting Q1 revenue of $8.8 million, a 9% increase year-over-year, but a net loss of $1.6 million due to planned investments. The company reiterated its full-year 2026 revenue guidance of $45 million to $50 million, representing 35% to 50% year-over-year growth. Strategic investments are being made in sales distribution, technology development, and product offerings, including new KPIs like Contracted Revenue ($22.9 million for remaining 2026) and Platform Placed Plan Value ($82 million in Q1 2026).
Key Highlights
- Reiterated full-year 2026 revenue guidance of $45M-$50M (35%-50% YoY growth).
- Q1 2026 total revenue was $8.8 million, an increase of 9% year-over-year.
- Q1 2026 net loss was $1.6 million, compared to net income of $0.5 million in prior year.
- Q1 2026 adjusted EBITDA was negative $1.3 million, compared to positive $1.2 million in prior year.
- Contracted Revenue for remaining three quarters of 2026 totaled approximately $22.9 million.
- Platform Placed Plan Value (PPPV) in Q1 2026 was $82 million.
- Ended the quarter with $10.3 million in cash and cash equivalents, including $7 million from PIPE financing.
- Sales and marketing expenses doubled to $2.3 million, representing 26% of revenue.
Price Impact
More from HIT